InvestorsHub Logo
Followers 36
Posts 10832
Boards Moderated 0
Alias Born 08/09/2017

Re: None

Sunday, 12/23/2018 11:13:32 PM

Sunday, December 23, 2018 11:13:32 PM

Post# of 108589
Word by Mysterium on the Quarterly Report. Part 3
"The third and final item that became apparent, was the iMedScan potential for dual-end revenues. iMedScan will serve to increase revenues for Toron and InMed via insurance and payment issues that were previously hard to navigate for the insured and the insurer,and it will also serve as a revenue generating stream from what I can best deduce forward as software sales and medical technology. So currently in the pocket, we have InMed, iMedscan improvements to InMed, with future healthcare acquisitions to come, and medical technology sales in tow."

" iMedScan provides ease of use for patients by simplifying their
check-in registration process, while at the same time reducing the healthcare providers’ administrative expenses and lost revenues by eliminating insurance rejections, denials or any results from erroneous or incomplete patient information verification. iMedScan’s revenue model presents an up-front income boost. However, its long term financial strength is derived from its tremendous back-end revenue stream"

"8-k by Sterling Issuer Services should be arriving shortly, with no exact time frame provided as of yet. Also to look forward to, would be the transfer of state and federal paperwork between Toron and InMed, which has already been filed and submitted, and is expected to be completed within range of 12/21/18. Again, that is not a date set in stone, as no one outside of the govt can really tell you the exact date someone inside the govt will finish their end of the paperwork. It's done when it's done. And finally, auditors are being selected so as to bring Toron forward as a fully reporting, SEC compliant company. Everything is falling into place."